The Wall Street Journal's 2008 CEO compensation survey is out. Most of the pharma CEOs make in the $16 million to $18 million range, and the highest-paid person on the list of pharma execs is Abbott's Miles White, who receives a little more than $18 million. Eli Lilly's new CEO, John Lechleiter, may feel a little shafted with a compensation package worth about $10 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.